T. Papo

16.7k total citations · 1 hit paper
245 papers, 6.4k citations indexed

About

T. Papo is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, T. Papo has authored 245 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Rheumatology, 60 papers in Pulmonary and Respiratory Medicine and 44 papers in Physiology. Recurrent topics in T. Papo's work include Systemic Lupus Erythematosus Research (53 papers), Vasculitis and related conditions (42 papers) and Sarcoidosis and Beryllium Toxicity Research (25 papers). T. Papo is often cited by papers focused on Systemic Lupus Erythematosus Research (53 papers), Vasculitis and related conditions (42 papers) and Sarcoidosis and Beryllium Toxicity Research (25 papers). T. Papo collaborates with scholars based in France, United States and Switzerland. T. Papo's co-authors include B. Wechsler, Jean‐Charles Piette, Karim Sacré, P Godeau, D. Lê Thi Huong, O Blétry, Bruno Varet, Irène Teyssandier, P Martin-Dupont and Jean‐Jacques Kiladjian and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

T. Papo

232 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

2002 843 citations T. Papo, Bruno Varet et al. profile →

Peers

Countries citing papers authored by T. Papo

Since Specialization

Citations

This map shows the geographic impact of T. Papo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Papo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Papo more than expected).

Fields of papers citing papers by T. Papo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Papo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Papo. The network helps show where T. Papo may publish in the future.

Co-authorship network of co-authors of T. Papo

This figure shows the co-authorship network connecting the top 25 collaborators of T. Papo. A scholar is included among the top collaborators of T. Papo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Papo. T. Papo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vascular liver disorders in patients with antiphospholipid syndrome: a national retrospective multicentre study 2025 ·Lara D. Veeken ·(unknown), (unknown), Cécile Yelnik, Ada Clarke, Matthias Papo, Zahir Amoura, M. Lambert, (unknown), Aurélie Plessier, (unknown), T. Papo, Pierre‐Emmanuel Rautou, N. Costedoat‐Chalumeau, Karim Sacré	0
2	Risk of systemic lupus erythematosus flare after COVID-19 hospitalization: A matched cohort study 2024 ·PLoS ONE ·Arthur Mageau, (unknown), Kankoé Sallah, T. Papo, Karim Sacré, Jean‐François Timsit	1
3	Brain microstructural damage through serial diffusion tensor imaging and outcomes in Susac syndrome: A prospective cohort study 2024 ·European Journal of Neurology ·Augustin Gaudemer, Marie-Cécile Henry–Feugeas, (unknown), (unknown), Isabelle Klein, Antoine Khalil, T. Papo, Karim Sacré	1
4	Criteria and non-criteria antiphospholipid autoantibodies screening in patients with late pregnancy morbidity: A cross-sectional study 2024 ·Placenta ·(unknown), Arthur Mageau, (unknown), Pascale Nicaise, (unknown), (unknown), (unknown), Valentine Marie Ferré, (unknown), T. Papo, Tiphaine Goulenok, Karim Sacré	2
5	Risk factors for severe hearing loss in Susac syndrome: A national cohort study 2024 ·European Journal of Neurology ·(unknown), Arthur Mageau, (unknown), Serge Doan, (unknown), Isabelle Klein, Tiphaine Goulenok, (unknown), Marie‐Paule Chauveheid, T. Papo, Karim Sacré, (unknown)	6
6	High incidence of immune‐mediated inflammatory diseases in sepsis survivors: A nationwide exposed‐nonexposed epidemiological study 2023 ·Journal of Internal Medicine ·Arthur Mageau, (unknown), Stéphane Ruckly, A I Strukov, T. Papo, Jean‐François Timsit, Karim Sacré	2
7	Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project 2022 ·Journal of Autoimmunity ·Arthur Mageau, (unknown), Valentine Marie Ferré, P. Nicaise‐Roland, Diane Descamps, (unknown), (unknown), (unknown), T. Papo, Tiphaine Goulenok, Nicolas Charles, Karim Sacré	7
8	Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation‐wide population‐based study over 10 years 2022 ·Respirology ·Arthur Mageau, Raphaël Borie, Bruno Crestani, Jean‐François Timsit, T. Papo, Karim Sacré	14
9	Infliximab to Treat Severe Paradoxical Reaction in HIV-Negative Tuberculous Meningoencephalitis 2021 ·Neurology ·Tiphaine Goulenok, Augustin Gaudemer, D. Rouzaud, Marie‐Paule Chauveheid, (unknown), Karim Sacré, T. Papo	4
10	Acquired factor V inhibitor: a nation‐wide study of 38 patients 2021 ·British Journal of Haematology ·Tiphaine Goulenok, (unknown), Dorothée Faille, Nadine Ajzenberg, Emmanuelle de Raucourt, Annabelle Dupont, Corinne Frère, Chloé James, (unknown), Lucia Rugeri, N. Schleinitz, Karim Sacré, T. Papo, (unknown)	7
11	Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient 2020 ·Infection ·Déborah Eshagh, Khadija Benali, Antoine Dossier, (unknown), D. Rouzaud, Tiphaine Goulenok, T. Papo, Karim Sacré	6
12	Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE) 2020 ·Vaccine ·(unknown), Tiphaine Goulenok, Mathilde Bahuaud, (unknown), Pièrre Aucouturier, Hélène Moins‐Teisserenc, Frédéric Batteux, T. Papo, Karim Sacré	7
13	Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus 2020 ·Arthritis & Rheumatology ·Fanny Saidoune, Guillaume Even, (unknown), (unknown), Anh‐Thu Gaston, Brigitte Escoubet, T. Papo, Nicolas Charles, Antonino Nicoletti, Karim Sacré	24
14	Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse 2019 ·European Journal of Internal Medicine ·(unknown), Arthur Mageau, Khadija Benali, Rémi Bertinchamp, (unknown), Quentin Raimbourg, Jean‐François Alexandra, Tiphaine Goulenok, Damien Van Gysel, T. Papo, Karim Sacré	11
15	Increased FDG-PET/CT pericardial uptake identifies acute pericarditis patients at high risk for relapse 2018 ·International Journal of Cardiology ·(unknown), Arthur Mageau, Khadija Benali, (unknown), Grégory Ducrocq, Jean‐François Alexandra, Damien Van Gysel, T. Papo, Karim Sacré	12
16	Immunoglobulin E plays an immunoregulatory role in lupus 2014 ·The Journal of Experimental Medicine ·Bárbara Dema, Nicolas Charles, Christophe Pellefigues, Tiffany K. Ricks, Ryo Suzuki, Chao Jiang, Jörg Scheffel, Sarfaraz Hasni, Victoria Hoffman, Mathieu Jablonski, Karim Sacré, Delphine Gobert, T. Papo, Éric Daugas, Steve P. Crampton, Silvia Bolland, Juan Rivera	73
17	Association of Sarcoidosis and Immune Thrombocytopenia 2011 ·Medicine ·Matthieu Mahévas, Laurent Chiche, Y. Uzunhan, M. Khellaf, (unknown), G. Le Guenno, (unknown), (unknown), Olivier Lidove, David Boutboul, Geneviève Dion, Jean-Pierre Ducroix, T. Papo, Yves Pachéco, N. Schleinitz, Marc Michel, Bertrand Godeau, Dominique Valeyre	18
18	Enzyme therapy in Fabry disease: severe adverse events associated with anti‐agalsidase cross‐reactive IgG antibodies 2009 ·British Journal of Clinical Pharmacology ·(unknown), Olivier Lidove, (unknown), (unknown), Chloé Ackaert, Pascale Nicaise, Philippe Arnaud, T. Papo	25
19	Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study 2008 ·Blood ·Bertrand Godeau, Raphaël Porcher, Olivier Fain, François Lefrère, Pierre Fenaux, Stéphane Chèze, Anne Vekhoff, Marie‐Paule Chauveheid, Jérôme Stirnemann, Lionel Galicier, Emmanuelle Bourgeois, Stéphanie Haïat, Bruno Varet, M Leporrier, T. Papo, Mehdi Khellaf, Marc Michel, Philippe Bierling	184
20	Pregnancy in relapsing polychondritis: twenty-five pregnancies in eleven patients. 1997 ·PubMed ·T. Papo, B. Wechsler, O Blétry, (unknown), P Godeau, Jean-Charles Piette	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact